← FDA DRUG APPROVALS

FDA ANDA · ANDA072600

CLOFIBRATE

Sponsor: TEVA

APPLICATION
ANDA072600
TYPE
ANDA
ORIGINAL APPROVAL
1991-07-25
LATEST ACTION
1998-05-27
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CLOFIBRATEDiscontinued
CLOFIBRATE 500MG · CAPSULE · ORAL

Approval history

1998-05-27Manufacturing (CMC) · Supplement 4AP
1997-04-01Labeling · Supplement 3AP
1993-03-23Labeling · Supplement 2AP
1992-11-13Manufacturing (CMC) · Supplement 1AP
1991-07-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →